Page 10 - Read Online

Page 4 of 4 Zhong. Hepatoma Res. 2026;12:54

Copyright
© The Author(s) 2026.

REFERENCES
1. Reig M, Sanduzzi-Zamparelli M, Forner A, et al. BCLC strategy for prognosis prediction and treatment recommendations: the 2026
update. J Hepatol. 2026;84:631-54. DOI PubMed
2. Zhong BY, Fan W, Guan JJ, et al. Combination locoregional and systemic therapies in hepatocellular carcinoma. Lancet Gastroenterol
Hepatol. 2025;10:369-86. DOI PubMed
3. Li X, Li S, Li Y, et al. Thermal ablation therapy for hepatocellular carcinoma: recurrence mechanisms and intervention strategies.
Hepatoma Res. 2025;11:25. DOI
4. Hall B, Ohs Z, Dervishi M, Stevens A, Sutter C, Davidson J. Yttrium-90 combination therapies in hepatocellular carcinoma: current
evidence and future directions. Hepatoma Res. 2026;12:20. DOI
5. Yu Z, You R, Wang C, et al. A baseline-lymphocyte-subset nomogram for predicting severe immune-related adverse events in
hepatocellular carcinoma patients receiving TACE plus immunotherapy. Hepatoma Res. 2025;11:29. DOI
6. Li C, Chen L, Bao H, Wang Y, Guo J, Zhu G. Synergistic era: practice and reflection on TACE combined with systemic therapy in
hepatocellular carcinoma. Hepatoma Res. 2026;12:36. DOI
7. Ma Y, Chen L, Li C, Li Y, Li G, Zhu H. Relationship between transarterial chemoembolization treatment frequency and prognosis in
hepatocellular carcinoma patients. Hepatoma Res. 2026;12:43. DOI

Disclaimer/Publisher’s Note: All statements, opinions, and data contained in this publication are solely those of the individual author(s) and
contributor(s) and do not necessarily reflect those of OAE and/or the editor(s). OAE and/or the editor(s) disclaim any responsibility for harm to
persons or property resulting from the use of any ideas, methods, instructions, or products mentioned in the content.

© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License
(https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing, adaptation, distribution and
reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and
the source, provide a link to the Creative Commons license, and indicate if changes were made.